相关实验视频
Updated: Jan 21, 2026

12:24
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
12.7K
在因子VIII测试中,从接受Efanesoctocog Alfa治疗的患者获得的输液后样本中存在差异
Jens Müller1, Martin Büchsel2, Behnaz Pezeshkpoor1
1Institute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, University of Bonn, Bonn, Germany.
Hamostaseologie
|January 19, 2026
概括
阿尔法 (efa) 的efanesoctocog引起了因子VIII (FVIII) 诊断测试中的差异. 输液后的样本显示过高估计了efa活性,特别是在高峰水平,在低谷水平的结果因使用的试验而有所不同.
科学领域:
- 血液学 血液学 血液学
- 临床诊断 临床诊断 临床诊断
- 药理学 药理学是指药理学的学科.
背景情况:
- 埃法尼索克托科格阿尔法 (efa) 是一种新型重组因子VIII (FVIII) 缩剂,旨在在血友病A治疗中延长半衰期.
- 由于efa的工程性质导致FVIII诊断试验中观察到的差异,最初是用尖样本观察到的.
研究的目的:
- 为了调查和描述FVIII测定差异,使用接受efa预防的患者的输液后样本.
- 为了比较不同FVIII诊断试验 (单阶段凝血试验和染色基质试验) 在患者样本中量化EFA活性时的性能.
主要方法:
- 对43名接受efa预防的男性患者 (每周一次或两次) 的回顾性分析.
- 在低谷和高峰水平测量FVIII活性,使用两个单阶段凝血试验 (OSCAs) 和一个染色基质试验 (FVIII CSA).
- 在不同的测定方法和患者组中确定并比较了渐进性恢复.
主要成果:
- 根据推的基于Actin FSL的OSCA确定的增量恢复在患者组之间是可比的.
- 基于AFS的OSCA和FVIII CSA都显示,相对于基于AFSL的OSCA,峰值水平对EFA活动的估计高出1.9倍.
- 在最低水平时,FVIII CSA表现出较低的高估值 (1.3倍) 与基于AFS的OSCA (1.9倍) 相比,相对于基于AFSL的OSCA.
结论:
- 在输液后的样本中,FVIII测定结果的差异显而易见,这些样本来自用efanesoctocog alfa.治疗的患者.
- 过高估计的程度在测试和采样时间 (高峰与低谷) 之间有所不同.
- 需要进一步调查,以了解这些测定差异背后的机制,并确定药物特定校准是否可以解决观察到的差异.
相关概念视频
Self-Discrepancy Theory
18.9K
One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.
18.9K
Self-Discrepancy and Its Effects
301
Self-discrepancy theory explains how people compare their actual self to their ideal and ought selves and how mismatches between these self-guides can lead to emotional distress. Developed by E. Tory Higgins, the theory distinguishes among three components of self-concept: the actual self, the ideal self, and the ought self. These refer respectively to how individuals perceive themselves, how they aspire to be, and how they believe they are obligated to be. Emotional well-being, self-esteem,...
301
Factors Affecting Protein-Drug Binding: Patient-Related Factors
307
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
307
Transcription Factors
82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
One-Compartment Model: IV Infusion
497
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
497
Factors Affecting Solubility
36.7K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
36.7K

